沈惠良, 王涧, 严丽英, 黄佳, 夏莹烨. 梅毒患者血清固定的影响因素分析[J]. 预防医学, 2021, 33(6): 589-591.
SHEN Huiliang, WANG Jian, YAN Liying, et al. Influencing factors for the serofast reaction in patients with syphilis. Preventive Medicine, 2021, 33(6): 589-591.
[1] 姜晓勇,卢珍玲,杨慧丽,等. 早期梅毒加用抗神经梅毒药物对梅毒血清固定的影响[J]. 皮肤病与性病,2019,41(4):486-488. [2] 赵洋,栾兴宝,杜天意,等. 梅毒血清固定影响因素及发生机制的研究进展[J]. 北京医学,2020,42(10):963-965. [3] LAWRENCE D,CRESSWELL F,WHETHAM J,et al.Syphilis treatment in the presence of HIV:the debate goes on[J]. Curr Opin Infect Dis,2015,28(1):44-52. [4] LIN L R,ZHENG W H,TONG M L,et al.Further evaluation of the characteristics of treponema pallidum-specific IgM antibody in syphilis serofast reaction patients[J]. Diagn Micr Infec Dis,2011,71(3):201-207. [5] 李维,刘双全. 梅毒血清固定机制的研究进展[J]. 微生物学免疫学进展,2018,46(3):82-85. [6] 徐超,林丽萍,马启超,等. 387例梅毒患者血清固定的影响因素分析[J]. 中国艾滋病性病,2018,24(7):733-734. [7] 史修波,贺国容,兰小琼,等. 梅毒患者正规治疗后血清固定的危险因素Logistic回归分析[J]. 山西医药杂志,2018,47(18):2214-2216. [8] 中华人民共和国国家卫生和计划生育委员会. 梅毒诊断:WS 273—2018[S]. 北京:中国标准出版社,2018. [9] 刘焕颜,梁晓冬,邓婕,等. 梅毒血清固定的产生及临床转归[J]. 中国麻风皮肤病杂志,2019,35(10):637-640. [10] LIU Y,BIAN Q Q,ZHANG S H,et al.Post-treatment serological changes in some patients with early syphilis exhibit a parabolic trend[J]. Int J STD AIDS,2019,30(14):1389-1396. [11] LIU A Y,ZANG W J,YUAN L L,et al.Latent syphilis among inpatients in an urban area of China[J]. Global J Health Sci,2015,7(3):249-253. [12] QIN J B,YANG T B,WANG H,et al.Potential predictors for serofast state after treatment among HIV-negative persons with syphilis in China: a systematic review and meta-analysis[J]. Iran J Public Health,2015,44(2):155-169. [13] LEEYAPHAN C,PUNYARATABANDHU P,JIAMTON S. Predictors of serological cure after treatment in patients with early syphilis:a retrospective observational study in Thailand[J]. Indian J Dermatol Venereol Leprol,2019,85(2)[2021-02-27]. https://pubmed.ncbi.nlm.nih.gov/30719988/. DOI:10.4103/ijdvl.IJDVL_810_17. [14] 钱亚珠. 苄星青霉素与阿奇霉素驱梅治疗的效果比较[J]. 皮肤病与性病,2018,40(6):822-823.
